Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2013

01-11-2013 | Poster presentation

PB.38: In the context of overdiagnosis, does size matter?

Authors: S Bhuva, I Haigh, M McMahon, B Dall, D Dodwell, N Sharma

Published in: Breast Cancer Research | Special Issue 1/2013

Login to get access

Excerpt

The Marmot Review showed that although breast screening saves lives, it is harmful through overdiagnosis - treating cancers that would not otherwise have ever become clinically apparent. Currently, there is no size threshold for recalling screening patients with calcifications. Our aim was to assess whether a minimum size threshold would reduce overdiagnosis. …
Metadata
Title
PB.38: In the context of overdiagnosis, does size matter?
Authors
S Bhuva
I Haigh
M McMahon
B Dall
D Dodwell
N Sharma
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3538

Other articles of this Special Issue 1/2013

Breast Cancer Research 1/2013 Go to the issue

Oral presentation

4.5: Diagnosing breast cancer in a high-risk cohort

Poster presentation

PB.40: Clinical recall audit: are we following national guidelines?

Poster presentation

PB.28: Is second-time vacuum-assisted biopsy effective in improving preoperative diagnosis rate of screen-detected DCIS?

Poster presentation

PB.05: MRI-guided vacuum-assisted breast biopsy at 3T: initial experience

Poster presentation

PB.53: Are ethnic minorities more likely to develop triple-negative breast cancer? A systematic review

Poster presentation

PB.04: MRI In lobular and mixed lobular/ductal carcinomas: can we preselect cases based on imaging appearance?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits